Kronos Bio, Inc. (KRON)

Kronos Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	70	73	92	766	1,674	-
Market Cap Growth	-7.15%	-20.92%	-87.96%	-54.25%	-	-
Enterprise Value	-56	-74	-117	458	1,291	-92
PE Ratio	-	-0.65	-0.69	-5.07	-18.92	-
PS Ratio	9.27	11.59	-	-	-	-
PB Ratio	0.51	0.46	0.38	2.22	3.60	-
P/FCF Ratio	-0.80	-0.92	-1.01	-6.27	-35.25	-
P/OCF Ratio	-0.81	-0.93	-1.01	-6.49	-44.15	-
EV/Sales Ratio	-6.38	-11.75	-	-	-	-
EV/EBITDA Ratio	0.43	0.69	0.91	-3.12	-16.20	5.91
EV/EBIT Ratio	0.42	0.66	0.88	-3.03	-15.26	5.69
EV/FCF Ratio	0.50	0.93	1.28	-3.75	-27.18	5.09
Debt / Equity Ratio	0.20	0.18	0.13	0.10	0.07	-0.02
Debt / EBITDA Ratio	-0.25	-0.26	-0.24	-0.23	-0.40	-0.03
Debt / FCF Ratio	-0.28	-0.36	-0.34	-0.28	-0.68	-0.03
Quick Ratio	8.09	7.09	11.18	25.06	32.29	34.18
Current Ratio	8.32	7.24	11.37	25.51	32.65	34.60
Asset Turnover	0.03	0.03	0	0	0	0
Interest Coverage	-	-	-	-	-21.74	-5371.33
Return on Equity (ROE)	-68.70%	-58.80%	-47.50%	-37.50%	-40.00%	105.70%
Return on Assets (ROA)	-52.00%	-45.00%	-40.40%	-33.60%	-28.80%	-28.00%
Return on Capital (ROIC)	-76.22%	-65.03%	-49.75%	-39.96%	-11.67%	74.06%
Earnings Yield	-165.54%	-154.57%	-144.51%	-19.73%	-5.28%	-
FCF Yield	-138.09%	-108.73%	-99.27%	-15.96%	-2.84%	-
Buyback Yield / Dilution	-4.15%	-2.75%	-2.64%	-236.38%	-208.35%	-8.69%
Total Shareholder Return	-4.15%	-2.75%	-2.64%	-236.38%	-208.35%	-8.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).